Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus

Ellen M. Ginzler, Daniel J. Wallace, Joan T. Merrill, Richard A. Furie, William Stohl, W. Winn Chatham, Arthur Weinstein, James D. McKay, W. Joseph McCune, Z. John Zhong, William W. Freimuth, Michelle A. Petri

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

Medicine & Life Sciences